Anuddin, Helen S.

HRN: 21-81-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
CEFTRIAXONE 1G (VIAL)
08/16/2022
08/22/2022
IV DRIP
900 Mg
Q24
PCAP D
Waiting Final Action 
08/16/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/16/2022
08/22/2022
IV DRIP
135mg
Q24
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: